To avoid the flare effect, as well as the GnRH-associated side effects (metabolic dysfunction and cardiovascular diseases), GnRH antagonists (cetrorelix, degarelix, abarelix, ozarelix, ganirelix, relugolix) were developed. The gene discussed is GNRH1; the disease is cardiovascular disorder.